FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/05/2023
Back to search
Official data from USPTO
VGENFLI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
04/05/2023
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/15/2021
Registration date
11/22/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/22/2022
Last transaction
11/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
KR
Examiner
JARAMILLO, JAVIER R
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SAM CHUN DANG PHARM. CO., LTD.
Representatives
Ziwen Zhu Locke Lord LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Ophthalmic preparations; ophthalmological preparations; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; topical anti-infective substances for the treatment of infections of the eye; pharmaceutical preparations for ocular use; pharmaceutical preparations for the prevention of ocular diseases; pharmaceutical preparations for the treatment of ocular diseases; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; medicines for human purposesfor the treatment of ophthalmic conditions; pharmaceutical preparations for diagnosis of ophthalmic conditions; ethical medicinal preparations for the treatment of ophthalmic conditions; drugs for medical purposesfor the treatment and prevention of ophthalmic conditions; therapeutic drugs and agents for the treatment of ophthalmic conditions; pharmaceutical preparations for the treatment and prevention of ophthalmic conditions; pharmaceutical preparations for the treatment or prevention of ophthalmologic diseases; pharmaceutical preparations for the treatment of angiogenesis diseases; pharmaceutical preparations for tumor treatment; nutraceutical preparations for therapeutic or medical purposesfor the treatment and prevention of ophthalmic conditions
Publications
History of USPTO decisions and trademark events.
23 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/15/2023
FIMP
FINAL DISPOSITION PROCESSED
03/15/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/22/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/06/2022
PUBO
PUBLISHED FOR OPPOSITION
09/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/17/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/27/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/27/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/27/2022
DOCK
ASSIGNED TO EXAMINER
06/02/2022
RFNT
REFUSAL PROCESSED BY IB
05/03/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/12/2022
RFRR
REFUSAL PROCESSED BY MPU
04/12/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/11/2022
CNRT
NON-FINAL ACTION WRITTEN
03/10/2022
DOCK
ASSIGNED TO EXAMINER
03/07/2022
MAFR
APPLICATION FILING RECEIPT MAILED
07/24/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/20/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/15/2021
Continuous trademark protection
Get notified about every new filing that threatens VGENFLI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.